Randomized phase III trial of APF530 versus palonosetron in the prevention of chemotherapy-induced nausea and vomiting in a subset of patients with breast cancer receiving moderately or highly emetogenic chemotherapy.
BMC Cancer
; 16: 166, 2016 Feb 26.
Article
em En
| MEDLINE
| ID: mdl-26921245
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Quinuclidinas
/
Vômito
/
Neoplasias da Mama
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Isoquinolinas
/
Antieméticos
/
Náusea
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Idioma:
En
Ano de publicação:
2016